Yukiomi Kushihashi, Tatsuo Masubuchi, Isaku Okamoto, Chihiro Fushimi, Morio Yamazaki, Hisashi Asano, Reo Aoki, Shota Fujii, Yukiko Asako, Yuichiro Tada
INTRODUCTION: Photoimmunotherapy (PIT) is a treatment wherein intravenous cetuximab sarotalocan sodium is administered followed by laser light irradiation. This treatment exhibits a specific antitumor effect if in tumors expressing the epidermal growth factor receptor, regardless of the carcinoma [Mitsunaga et al.: Nat Med. 2011;17(12):1685-91, Sato et al.: ACS Cent Sci. 2018;4(11):1559-69, Nakajima et al.: Cancer Sci. 2018;109(9):2889-96]. The current indications are unresectable, locally advanced, or locally recurrent head and neck cancer...
2024: Case Reports in Oncology